Showing 1 - 20 results of 45 for search '(( ct ((largest decrease) OR (larger decrease)) ) OR ( hla ((e decrease) OR (nn decrease)) ))', query time: 0.47s Refine Results
  1. 1

    All-Atom Simulations Reveal the Effect of Membrane Composition on the Signaling of the NKG2A/CD94/HLA‑E Immune Receptor Complex by Martin Ljubič (15680161)

    Published 2024
    “…In this study, we employed all-atom molecular dynamics simulations to investigate the impact of different membrane compositions on the conformational dynamics of the NKG2A/CD94/HLA-E immune receptor complex, a key negative regulator of natural killer cell cytotoxic activity. …”
  2. 2
  3. 3
  4. 4

    Image 6_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg by Eisa Mahyari (9681962)

    Published 2025
    “…Using cellular indexing of transcriptomes and epitopes (CITE-Seq) in a well-characterized cohort of 25 subjects—including AS (HLA-B27<sup>pos</sup>), AS+AAU (HLA-B27<sup>pos</sup>), AAU (HLA-B27<sup>pos</sup>), HCs (HLA-B27<sup>pos</sup>), and HCs (HLA-B27<sup>neg</sup>); N = 5/group—we identified transcriptomic differences at the single-cell level, along with differentially expressed cell surface markers. …”
  5. 5

    Image 9_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg by Eisa Mahyari (9681962)

    Published 2025
    “…Using cellular indexing of transcriptomes and epitopes (CITE-Seq) in a well-characterized cohort of 25 subjects—including AS (HLA-B27<sup>pos</sup>), AS+AAU (HLA-B27<sup>pos</sup>), AAU (HLA-B27<sup>pos</sup>), HCs (HLA-B27<sup>pos</sup>), and HCs (HLA-B27<sup>neg</sup>); N = 5/group—we identified transcriptomic differences at the single-cell level, along with differentially expressed cell surface markers. …”
  6. 6

    Data Sheet 1_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.docx by Eisa Mahyari (9681962)

    Published 2025
    “…Using cellular indexing of transcriptomes and epitopes (CITE-Seq) in a well-characterized cohort of 25 subjects—including AS (HLA-B27<sup>pos</sup>), AS+AAU (HLA-B27<sup>pos</sup>), AAU (HLA-B27<sup>pos</sup>), HCs (HLA-B27<sup>pos</sup>), and HCs (HLA-B27<sup>neg</sup>); N = 5/group—we identified transcriptomic differences at the single-cell level, along with differentially expressed cell surface markers. …”
  7. 7

    Image 5_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg by Eisa Mahyari (9681962)

    Published 2025
    “…Using cellular indexing of transcriptomes and epitopes (CITE-Seq) in a well-characterized cohort of 25 subjects—including AS (HLA-B27<sup>pos</sup>), AS+AAU (HLA-B27<sup>pos</sup>), AAU (HLA-B27<sup>pos</sup>), HCs (HLA-B27<sup>pos</sup>), and HCs (HLA-B27<sup>neg</sup>); N = 5/group—we identified transcriptomic differences at the single-cell level, along with differentially expressed cell surface markers. …”
  8. 8

    Data Sheet 2_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.xlsx by Eisa Mahyari (9681962)

    Published 2025
    “…Using cellular indexing of transcriptomes and epitopes (CITE-Seq) in a well-characterized cohort of 25 subjects—including AS (HLA-B27<sup>pos</sup>), AS+AAU (HLA-B27<sup>pos</sup>), AAU (HLA-B27<sup>pos</sup>), HCs (HLA-B27<sup>pos</sup>), and HCs (HLA-B27<sup>neg</sup>); N = 5/group—we identified transcriptomic differences at the single-cell level, along with differentially expressed cell surface markers. …”
  9. 9

    Image 3_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg by Eisa Mahyari (9681962)

    Published 2025
    “…Using cellular indexing of transcriptomes and epitopes (CITE-Seq) in a well-characterized cohort of 25 subjects—including AS (HLA-B27<sup>pos</sup>), AS+AAU (HLA-B27<sup>pos</sup>), AAU (HLA-B27<sup>pos</sup>), HCs (HLA-B27<sup>pos</sup>), and HCs (HLA-B27<sup>neg</sup>); N = 5/group—we identified transcriptomic differences at the single-cell level, along with differentially expressed cell surface markers. …”
  10. 10

    Data Sheet 3_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.xlsx by Eisa Mahyari (9681962)

    Published 2025
    “…Using cellular indexing of transcriptomes and epitopes (CITE-Seq) in a well-characterized cohort of 25 subjects—including AS (HLA-B27<sup>pos</sup>), AS+AAU (HLA-B27<sup>pos</sup>), AAU (HLA-B27<sup>pos</sup>), HCs (HLA-B27<sup>pos</sup>), and HCs (HLA-B27<sup>neg</sup>); N = 5/group—we identified transcriptomic differences at the single-cell level, along with differentially expressed cell surface markers. …”
  11. 11

    Image 7_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpg by Eisa Mahyari (9681962)

    Published 2025
    “…Using cellular indexing of transcriptomes and epitopes (CITE-Seq) in a well-characterized cohort of 25 subjects—including AS (HLA-B27<sup>pos</sup>), AS+AAU (HLA-B27<sup>pos</sup>), AAU (HLA-B27<sup>pos</sup>), HCs (HLA-B27<sup>pos</sup>), and HCs (HLA-B27<sup>neg</sup>); N = 5/group—we identified transcriptomic differences at the single-cell level, along with differentially expressed cell surface markers. …”
  12. 12

    Image 1_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg by Eisa Mahyari (9681962)

    Published 2025
    “…Using cellular indexing of transcriptomes and epitopes (CITE-Seq) in a well-characterized cohort of 25 subjects—including AS (HLA-B27<sup>pos</sup>), AS+AAU (HLA-B27<sup>pos</sup>), AAU (HLA-B27<sup>pos</sup>), HCs (HLA-B27<sup>pos</sup>), and HCs (HLA-B27<sup>neg</sup>); N = 5/group—we identified transcriptomic differences at the single-cell level, along with differentially expressed cell surface markers. …”
  13. 13

    Image 2_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg by Eisa Mahyari (9681962)

    Published 2025
    “…Using cellular indexing of transcriptomes and epitopes (CITE-Seq) in a well-characterized cohort of 25 subjects—including AS (HLA-B27<sup>pos</sup>), AS+AAU (HLA-B27<sup>pos</sup>), AAU (HLA-B27<sup>pos</sup>), HCs (HLA-B27<sup>pos</sup>), and HCs (HLA-B27<sup>neg</sup>); N = 5/group—we identified transcriptomic differences at the single-cell level, along with differentially expressed cell surface markers. …”
  14. 14

    Image 4_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg by Eisa Mahyari (9681962)

    Published 2025
    “…Using cellular indexing of transcriptomes and epitopes (CITE-Seq) in a well-characterized cohort of 25 subjects—including AS (HLA-B27<sup>pos</sup>), AS+AAU (HLA-B27<sup>pos</sup>), AAU (HLA-B27<sup>pos</sup>), HCs (HLA-B27<sup>pos</sup>), and HCs (HLA-B27<sup>neg</sup>); N = 5/group—we identified transcriptomic differences at the single-cell level, along with differentially expressed cell surface markers. …”
  15. 15

    Image 8_Divergent B-cell and cytotoxic TNK cell activation signatures in HLA-B27-associated ankylosing spondylitis and acute anterior uveitis.jpeg by Eisa Mahyari (9681962)

    Published 2025
    “…Using cellular indexing of transcriptomes and epitopes (CITE-Seq) in a well-characterized cohort of 25 subjects—including AS (HLA-B27<sup>pos</sup>), AS+AAU (HLA-B27<sup>pos</sup>), AAU (HLA-B27<sup>pos</sup>), HCs (HLA-B27<sup>pos</sup>), and HCs (HLA-B27<sup>neg</sup>); N = 5/group—we identified transcriptomic differences at the single-cell level, along with differentially expressed cell surface markers. …”
  16. 16
  17. 17
  18. 18
  19. 19

    Low <i>MAP1LC3C</i> expression in LUSC correlates with low cancer immunity. by Lydie M. O. Barbeau (5941712)

    Published 2025
    “…Heat maps ranked for <i>MAP1LC3C</i> expression for B) myeloid and C) lymphoid immune cells’ gene signatures, D) HLA class I and E) HLA class II, HLA chaperones and <i>CIITA</i>, F) immune checkpoints on APCs/tumor cells and G) immune checkpoints on T-cells. …”
  20. 20

    Data Sheet 1_Correlation analysis of osteoporosis and vertebral endplate defects using CT and MRI imaging: a retrospective cross-sectional study.pdf by Song Hao (5700608)

    Published 2025
    “…</p>Methods<p>Computed tomography (CT), magnetic resonance imaging (MRI), bone mineral density (BMD) and other relevant imaging data, as well as age, sex, body mass index (BMI), and degree of low back pain data, were retrospectively analysed. …”